NCT02024204View on ClinicalTrials.gov

Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 9, 2014

Primary Completion Date

May 17, 2017

Study Completion Date

May 17, 2017

Conditions
Lung DiseasesMedication Compliance
Interventions
DRUG

Fluticasone propionate 230mcg for 3 Months

DRUG

Current Treatment or no treatment

Patients who had symptoms at monitoring visit but are now controlled at V1 will be asked to continue their current treatment (or no treatment) and will continue with the study. They will not be provided with any medications.

DRUG

Salmeterol 21mcg for 3 Months

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
collaborator

National Institute for Occupational Safety and Health (NIOSH/CDC)

FED

lead

NYU Langone Health

OTHER

NCT02024204 - Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program | Biotech Hunter | Biotech Hunter